Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 7, 2012; 18(5): 458-465
Published online Feb 7, 2012. doi: 10.3748/wjg.v18.i5.458
Published online Feb 7, 2012. doi: 10.3748/wjg.v18.i5.458
Table 1 Laboratory data on admission and location of tumours
Total | Intrahepatic | Perihilar | Distal | P | |
(n = 69) | (n = 12) | (n = 38) | (n = 19) | value1 | |
Total bilirubin (mmol/L) | 178 (158) | 45 (109) | 216 (163) | 188 (131) | 0.003 |
Conjugated bilirubin (mmol/L) | 140 (122) | 31 (87) | 170 (123) | 151 (102) | 0.002 |
INR | 1.2 (0.7) | 1.1 (0.1) | 1.0 (0.1) | 1.6 (1.1) | 0.005 |
Table 2 Types of surgical resection
Types of surgery | Patients (n = 12) |
Left hemihepatectomy | 2 |
Right hemihepatectomy | 1 |
Segmental hepatic resections | 2 |
Extrahepatic bile duct resection | 5 |
Whipple’s procedure | 2 |
Table 3 Tumour histology, degree of differentiation, diameter, margin, perineural and lymph node involvements by tumour location n (%)
Total | Intrahepatic | Perihilar | Distal | P | |
(n = 12) | (n = 3) | (n = 6) | (n = 3) | value1 | |
Tumour histology | |||||
Adenocarcinoma | 11 (92) | 2 (18%) | 6 (55%) | 3 (27) | |
Other | 1 (8) | 1 (100%) | 0 | 0 | |
Degree of differentiation | |||||
Well | 5 (42) | 2 (40%) | 2 (40%) | 1 (20) | |
Moderate | 6 (50) | 1 (17%) | 3 (50%) | 2 (34) | |
Poor | 1 (8) | 0 | 1 (100%) | 0 | |
Tumour diameter, cm | |||||
Size, mean ± SD | 9.6 ± 15.2 | 27.1 ± 24.3 | 2.8 ± 2.2 | 5.7 ± 15.2 | 0.0481 |
Margin | |||||
Negative | 7 (58) | 3 (43) | 3 (43) | 1 (14) | |
Positive | 5 (42) | 0 | 3 (60) | 2 (40) | |
Lymph node involvement | |||||
Negative | 8 (67) | 2 (25) | 4 (50) | 2 (25) | |
Positive | 4 (33) | 1 (25) | 2 (50) | 1 (25) | |
Perineural involvement | |||||
Negative | 5 (42) | 3 (60) | 2 (40) | 0 | |
Positive | 7 (58) | 0 | 4 (57) | 3 (43) | |
Lymphovascular invasion | |||||
Negative | 7 (58) | 2 (29) | 4 (57) | 1 (14) | |
Positive | 5 (42) | 1 (20) | 2 (40) | 2 (40) |
Table 4 Univariate analysis of different variables in relation to survival
Variables | Survival rates (%) | P value | ||
1-year | 2-year | 3-year | ||
Jaundice | 0.038 | |||
Absent | 40 | 19 | 9 | |
Present | 19 | 6 | 2 | |
Staging | 0.016 | |||
Stage 1 | 43 | 17 | 9 | |
Stage 2 | 43 | 14 | 0 | |
Stage 3 | 12 | 4 | 0 | |
Stage 4 | 5 | 0 | 0 | |
Surgery (curative or palliative) | 0.017 | |||
No | 13 | 10 | 0 | |
Yes | 45 | 9 | 9 | |
Curative resection | 0.002 | |||
No | 14 | 8 | 0 | |
Yes | 67 | 17 | 17 | |
Type (among resected patient) | 0.003 | |||
Intrahepatic | 100 | 33 | 33 | |
Perihilar | 67 | 17 | 17 | |
Distal | 33 | 0 | 0 | |
Type (among all patient) | 0.027 | |||
Intrahepatic | 50 | 23 | 11 | |
Perihilar | 18 | 6 | 3 | |
Distal | 16 | 5 | 0 | |
Histology | 0.032 | |||
Well | 80 | 40 | 40 | |
Moderate and poor | 57 | 0 | 0 | |
Margin involvement | 0.013 | |||
Negative | 86 | 29 | 29 | |
Positive | 40 | 0 | 0 |
- Citation: Yusoff AR, Abdul Razak MM, Yoong BK, Vijeyasingam R, Siti ZM. Survival analysis of cholangiocarcinoma: A 10-year experience in Malaysia. World J Gastroenterol 2012; 18(5): 458-465
- URL: https://www.wjgnet.com/1007-9327/full/v18/i5/458.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i5.458